ABEONA THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.5 USD | +1.12% |
|
-0.44% | -10.18% |
| 05-30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
| 05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 184M | - | - | - | |||
| 56.61B | - | |||||
| 39.62B | ||||||
| 39.25B | ||||||
| 28.28B | ||||||
| 26.44B |
